Veterinary Cro And Cdmo Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

The global veterinary CRO and CDMO market encompasses contract research organizations that conduct preclinical and clinical trials for animal health products, as well as contract development and manufacturing organizations that handle formulation, production, and regulatory support services. Market sizing in 2025 ranges from approximately $7.73 billion to $7.94 billion depending on the methodology used, with most industry estimates converging around $7.82 billion. No government or official statistical agency publishes dedicated figures for this market segment, so all available data comes from commercial market research providers.

• •Market valued at $7.82 billion in 2025, with projected growth to between $11.42 billion and $17.56 billion by 2030-2035
• •All market sizing figures originate from commercial research firms rather than official government statistical agencies
• •Services span drug discovery, preclinical testing, clinical trials, formulation development, and manufacturing for veterinary therapeutics and vaccines

The companion animal segment is expanding rapidly as pet ownership rises globally, particularly in emerging economies where middle-class populations increasingly view pets as family members. This trend drives demand for new veterinary pharmaceuticals, vaccines, and specialty pet foods requiring rigorous safety and efficacy testing. Simultaneously, the livestock sector faces pressure to reduce antibiotic use and develop alternatives, creating substantial opportunities for contract research and manufacturing services.

• •Rising pet humanization trends fuel demand for advanced veterinary therapeutics and preventive care products
• •Livestock industry needs for disease prevention and antibiotic alternatives drive investment in veterinary vaccine development
• •Stringent regulatory requirements and the technical complexity of veterinary product development push companies toward specialized outsourcing partners

The market is typically segmented by service type into CRO services covering research and clinical development, and CDMO services encompassing manufacturing and formulation support. Biologics and vaccines represent the largest therapeutic category, followed by small molecule pharmaceuticals and medicated feed additives. Geographically, North America commands the largest market share due to its well-established companion animal industry and robust regulatory frameworks, while Asia-Pacific is emerging as the fastest-growing region.

• •North America leads with approximately 40% market share, supported by high pet ownership rates and advanced veterinary healthcare infrastructure
• •Europe represents the second-largest regional market, with strong demand driven by strict animal welfare and food safety regulations
• •Asia-Pacific is the fastest-growing region, propelled by expanding livestock sectors and increasing companion animal adoption in countries like China and India

What are the recent trends and outlook?

The market is moving toward more integrated service models that combine research, development, and manufacturing capabilities under single contracts, reducing complexity for clients. Digital transformation and automation in research processes, along with growing emphasis on sustainable manufacturing practices, are reshaping operational approaches. The sector is expected to maintain its strong growth trajectory through the coming decade as the convergence of human and veterinary medicine drives innovation and expands the addressable market.

• •Integrated CRO-CDMO service models gaining traction as clients seek end-to-end solutions for faster time-to-market
• •Increased focus on regulatory harmonization across regions is facilitating global development strategies for veterinary products
• •Emerging technologies such as monoclonal antibodies and gene therapies are creating new opportunities for specialized contract research services